Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment
Work
Year: 2024
Type: article
Source: Journal of Controlled Release
Institutions Tianjin Medical University, Hebei Medical University, Fourth Hospital of Hebei Medical University, Peking University, State Key Laboratory of Natural and Biomimetic Drugs
Cites: 45
Cited by: 11
Related to: 10
FWCI: 5.747
Citation percentile (by year/subfield): 100
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed